82 related articles for article (PubMed ID: 25379865)
1. A multimeric carcinoembryonic antigen signal inhibits the activation of human T cells by a SHP-independent mechanism: a potential mechanism for tumor-mediated suppression of T-cell immunity.
Lee KA; Bae EA; Song YC; Kim EK; Lee YS; Kim TG; Kang CY
Int J Cancer; 2015 Jun; 136(11):2579-87. PubMed ID: 25379865
[TBL] [Abstract][Full Text] [Related]
2. Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA.
Nolan KF; Yun CO; Akamatsu Y; Murphy JC; Leung SO; Beecham EJ; Junghans RP
Clin Cancer Res; 1999 Dec; 5(12):3928-41. PubMed ID: 10632322
[TBL] [Abstract][Full Text] [Related]
3. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
[TBL] [Abstract][Full Text] [Related]
4. A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA.
Hombach A; Koch D; Sircar R; Heuser C; Diehl V; Kruis W; Pohl C; Abken H
Gene Ther; 1999 Feb; 6(2):300-4. PubMed ID: 10435115
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.
Saha A; Chatterjee SK; Foon KA; Primus FJ; Sreedharan S; Mohanty K; Bhattacharya-Chatterjee M
Cancer Res; 2004 Jul; 64(14):4995-5003. PubMed ID: 15256474
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins.
Ma Q; DeMarte L; Wang Y; Stanners CP; Junghans RP
Cancer Gene Ther; 2004 Apr; 11(4):297-306. PubMed ID: 15002034
[TBL] [Abstract][Full Text] [Related]
7. Vaccine therapy of established tumors in the absence of autoimmunity.
Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection.
Zhang J; Somani AK; Yuen D; Yang Y; Love PE; Siminovitch KA
J Immunol; 1999 Sep; 163(6):3012-21. PubMed ID: 10477564
[TBL] [Abstract][Full Text] [Related]
9. SHP-1 dephosphorylates 3BP2 and potentially downregulates 3BP2-mediated T cell antigen receptor signaling.
Yu Z; Maoui M; Zhao ZJ; Li Y; Shen SH
FEBS J; 2006 May; 273(10):2195-205. PubMed ID: 16649996
[TBL] [Abstract][Full Text] [Related]
10. Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice.
Höchst B; Schildberg FA; Böttcher J; Metzger C; Huss S; Türler A; Overhaus M; Knoblich A; Schneider B; Pantelis D; Kurts C; Kalff JC; Knolle P; Diehl L
Hepatology; 2012 Nov; 56(5):1924-33. PubMed ID: 22610745
[TBL] [Abstract][Full Text] [Related]
11. Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity.
Hodge JW; McLaughlin JP; Abrams SI; Shupert WL; Schlom J; Kantor JA
Cancer Res; 1995 Aug; 55(16):3598-603. PubMed ID: 7543017
[TBL] [Abstract][Full Text] [Related]
12. [T lymphocytes with chimeric receptor induce carcinoembryonic antigen-positive specific gastric carcinoma cells apoptosis].
Xu HY; Xu L; Gao JH; Li KZ; Dou KF
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1053-7. PubMed ID: 17672971
[TBL] [Abstract][Full Text] [Related]
13. TRAIL-receptor costimulation inhibits proximal TCR signaling and suppresses human T cell activation and proliferation.
Lehnert C; Weiswange M; Jeremias I; Bayer C; Grunert M; Debatin KM; Strauss G
J Immunol; 2014 Oct; 193(8):4021-31. PubMed ID: 25217163
[TBL] [Abstract][Full Text] [Related]
14. Neem leaf glycoprotein enhances carcinoembryonic antigen presentation of dendritic cells to T and B cells for induction of anti-tumor immunity by allowing generation of immune effector/memory response.
Sarkar K; Goswami S; Roy S; Mallick A; Chakraborty K; Bose A; Baral R
Int Immunopharmacol; 2010 Aug; 10(8):865-74. PubMed ID: 20472099
[TBL] [Abstract][Full Text] [Related]
15. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.
Tsang KY; Zhu M; Even J; Gulley J; Arlen P; Schlom J
Cancer Res; 2001 Oct; 61(20):7568-76. PubMed ID: 11606396
[TBL] [Abstract][Full Text] [Related]
16. An entirely humanized CD3 zeta-chain signaling receptor that directs peripheral blood t cells to specific lysis of carcinoembryonic antigen-positive tumor cells.
Hombach A; Schneider C; Sent D; Koch D; Willemsen RA; Diehl V; Kruis W; Bolhuis RL; Pohl C; Abken H
Int J Cancer; 2000 Oct; 88(1):115-20. PubMed ID: 10962448
[TBL] [Abstract][Full Text] [Related]
17. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction.
Newton-Nash DK; Newman PJ
J Immunol; 1999 Jul; 163(2):682-8. PubMed ID: 10395658
[TBL] [Abstract][Full Text] [Related]
18. Surface expression of hemopoietic cell phosphatase fails to complement CD45 deficiency and inhibits TCR-mediated signal transduction in a Jurkat T cell clone.
Musci MA; Beaves SL; Ross SE; Yi T; Koretzky GA
J Immunol; 1997 Feb; 158(4):1565-71. PubMed ID: 9029091
[TBL] [Abstract][Full Text] [Related]
19. Novel system for generating cytotoxic effector lymphocytes using carcinoembryonic antigen (CEA) peptide and cultured dendritic cells.
Ohta K; Yamaguchi Y; Shimizu K; Miyahara E; Toge T
Anticancer Res; 2002; 22(5):2597-606. PubMed ID: 12529970
[TBL] [Abstract][Full Text] [Related]
20. Construction and molecular characterization of human chimeric T-cell antigen receptors specific for carcinoembryonic antigen.
Shirasu N; Shibaguci H; Kuroki M; Yamada H; Kuroki M
Anticancer Res; 2010 Jul; 30(7):2731-8. PubMed ID: 20683006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
